Wound Care - Southern Africa

  • Southern Africa
  • Revenue in the Wound Care market amounts to US$16.69m in 2024. The market is expected to grow annually by 0.85% (CAGR 2024-2029).
  • In global comparison, most revenue is generated in the United States (US$1,052m in 2024).
  • In relation to total population figures, per person revenues of US$0.24 are generated in 2024.

Key regions: United States, Indonesia, Germany, Europe, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care market in Southern Africa is experiencing significant growth and development due to various factors.

Customer preferences:
Customers in Southern Africa have shown a growing preference for advanced wound care products and treatments. This can be attributed to increasing awareness about the importance of proper wound care and the availability of innovative products in the market. Customers are seeking products that promote faster healing, reduce pain, and minimize the risk of infection. They are also looking for solutions that are easy to use and provide long-lasting results. As a result, there is a growing demand for products such as wound dressings, wound closure devices, and wound healing agents.

Trends in the market:
One of the key trends in the Wound Care market in Southern Africa is the adoption of advanced wound dressings. These dressings are designed to provide a moist wound healing environment, which promotes faster healing and reduces the risk of infection. Advanced wound dressings also offer superior absorption capabilities and can be used for a longer duration, reducing the need for frequent dressing changes. This trend is driven by the increasing prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, which require specialized care. Another trend in the market is the growing popularity of negative pressure wound therapy (NPWT). NPWT is a non-invasive treatment that uses controlled suction to promote wound healing. It is particularly effective in managing complex wounds, such as surgical wounds, traumatic wounds, and chronic ulcers. The demand for NPWT is driven by its ability to accelerate wound healing, reduce the risk of infection, and improve patient outcomes.

Local special circumstances:
Southern Africa faces unique challenges in wound care due to factors such as limited access to healthcare facilities, inadequate infrastructure, and a high burden of chronic diseases. These circumstances have led to a higher prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers. As a result, there is a greater need for specialized wound care products and treatments. Additionally, the region has a diverse population with varying healthcare needs and cultural preferences. This necessitates the development of products and services that are tailored to the local context.

Underlying macroeconomic factors:
The development of the Wound Care market in Southern Africa is also influenced by underlying macroeconomic factors. The region is experiencing economic growth, which has led to an increase in disposable income and improved access to healthcare services. This has resulted in a higher demand for healthcare products and services, including wound care. Additionally, advancements in technology and healthcare infrastructure have made it easier for companies to enter the market and distribute their products. These factors have contributed to the overall growth and development of the Wound Care market in Southern Africa.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)